Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
INFLUENCE OF NUMBER OF HYPERTENSION MEDICATIONS AND CIRCADIAN TIME OF TREATMENT ON CARDIOVASCULAR MORBIDITY AND MORTALITY — Ramon C Hermida (2011) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
INFLUENCE OF NUMBER OF HYPERTENSION MEDICATIONS AND CIRCADIAN TIME OF TREATMENT ON CARDIOVASCULAR MORBIDITY AND MORTALITY
Shared by
Ramon C Hermida
Universidade de Vigo
INFLUENCE OF NUMBER OF HYPERTENSION MEDICATIONS AND CIRCADIAN TIME OF TREATMENT ON CARDIOVASCULAR MORBIDITY AND MORTALITY
Article
2011
en
Authors
+1 more
Ramon C Hermida
Universidade de Vigo
DA
Diana E. Ayala
AM
Artemio Mojón
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2012
Cardiovascular Risk of Essential Hypertension: Influence of Class, Number, and Treatment-Time Regimen of Hypertension Medications
Ramon C Hermida
,
Diana E. Ayala
,
Artemio Mojón
,
José R. Fernández
Article
2010
INFLUENCE OF CIRCADIAN TIME OF HYPERTENSION TREATMENT ON CARDIOVASCULAR RISK: RESULTS OF THE MAPEC STUDY
Ramon C Hermida
,
Diana E. Ayala
,
Artemio Mojón
,
José R. Fernández
Article
2012
Cardiovascular Risk of Resistant Hypertension: Dependence on Treatment-Time Regimen of Blood Pressure–Lowering Medications
Diana E. Ayala
,
Ramon C Hermida
,
Artemio Mojón
,
José R. Fernández
Article
2014
Risk of new-onset diabetes: influence of class and treatment-time regimen of hypertension medications
Ramon C Hermida
,
Diana E. Ayala
,
Artemio Mojón
,
José R. Fernández
Article
2015
Influence of class and treatment-time regimen of hypertension medications on the risk of developing chronic kidney disease
Ramon C Hermida
,
Diana E. Ayala
,
Artemio Mojón
,
José R. Fernández
Discussion(0)
No comments yet. Be the first to comment.